Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 9/2015

01-09-2015 | Symposium: Research Advances After a Decade of War

Preventing Heterotopic Ossification in Combat Casualties—Which Models Are Best Suited for Clinical Use?

Authors: Keith A. Alfieri, MD, Benjamin K. Potter, MD, Thomas A. Davis, PhD, Matthew B. Wagner, PhD, Eric A. Elster, MD, Jonathan A. Forsberg, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 9/2015

Login to get access

Abstract

Background

To prevent symptomatic heterotopic ossification (HO) and guide primary prophylaxis in patients with combat wounds, physicians require risk stratification methods that can be used early in the postinjury period. There are no validated models to help guide clinicians in the treatment for this common and potentially disabling condition.

Questions/purposes

We developed three prognostic models designed to estimate the likelihood of wound-specific HO formation and compared them using receiver operating characteristic (ROC) curve analysis and decision curve analysis (DCA) to determine (1) which model is most accurate; and (2) which technique is best suited for clinical use.

Methods

We obtained muscle biopsies from 87 combat wounds during the first débridement in the United States, all of which were evaluated radiographically for development of HO at a minimum of 2 months postinjury. The criterion for determining the presence of HO was the ability to see radiographic evidence of ectopic bone formation within the zone of injury. We then quantified relative gene expression from 190 wound healing, osteogenic, and vascular genes. Using these data, we developed an Artificial Neural Network, Random Forest, and a Least Absolute Shrinkage and Selection Operator (LASSO) Logistic Regression model designed to estimate the likelihood of eventual wound-specific HO formation. HO was defined as any HO visible on the plain film within the zone of injury. We compared the models accuracy using area under the ROC curve (area under the curve [AUC]) as well as DCA to determine which model, if any, was better suited for clinical use. In general, the AUC compares models based solely on accuracy, whereas DCA compares their clinical utility after weighing the consequences of under- or overtreatment of a particular disorder.

Results

Both the Artificial Neural Network and the LASSO logistic regression models were relatively accurate with AUCs of 0.78 (95% confidence interval [CI], 0.72–0.83) and 0.75 (95% CI, 0.71–0.78), respectively. The Random Forest model returned an AUC of only 0.53 (95% CI, 0.48–0.59), marginally better than chance alone. Using DCA, the Artificial Neural Network model demonstrated the highest net benefit over the broadest range of threshold probabilities, indicating that it is perhaps better suited for clinical use than the LASSO logistic regression model. Specifically, if only patients with greater than 25% risk of developing HO received prophylaxis, for every 100 patients, use of the Artificial Network Model would result in six fewer patients who unnecessarily receive prophylaxis compared with using the LASSO regression model while not missing any patients who might benefit from it.

Conclusions

Our findings suggest that it is possible to risk-stratify combat wounds with regard to eventual HO formation early in the débridement process. Using these data, the Artificial Neural Network model may lead to better patient selection when compared with the LASSO logistic regression approach. Future prospective studies are necessary to validate these findings while focusing on symptomatic HO as the endpoint of interest.

Level of Evidence

Level III, prognostic study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–935.PubMedCrossRef Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–935.PubMedCrossRef
2.
go back to reference Davis TA, O’Brien FP, Anam K, Grijalva S, Potter BK, Elster EA. Heterotopic ossification in complex orthopaedic combat wounds: quantification and characterization of osteogenic precursor cell activity in traumatized muscle. J Bone Joint Surg Am. 2011;93:1122–1131.PubMed Davis TA, O’Brien FP, Anam K, Grijalva S, Potter BK, Elster EA. Heterotopic ossification in complex orthopaedic combat wounds: quantification and characterization of osteogenic precursor cell activity in traumatized muscle. J Bone Joint Surg Am. 2011;93:1122–1131.PubMed
3.
go back to reference Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC, Tadaki D, Gage FA, Stojadinovic A, Elster EA. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am. 2009;91:1084–1091.PubMedCrossRef Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC, Tadaki D, Gage FA, Stojadinovic A, Elster EA. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am. 2009;91:1084–1091.PubMedCrossRef
4.
go back to reference Forsberg JA, Potter BK, Polfer EM, Safford SD, Elster EA. Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds? Clin Orthop Relat Res. 2014;472:2845–2854.PubMedCrossRef Forsberg JA, Potter BK, Polfer EM, Safford SD, Elster EA. Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds? Clin Orthop Relat Res. 2014;472:2845–2854.PubMedCrossRef
5.
go back to reference Forsberg JA, Sjoberg D, Chen Q-R, Vickers A, Healey JH. Treating metastatic disease: Which survival model is best suited for the clinic? Clin Orthop Relat Res. 2013;471:843–850.PubMedCentralPubMedCrossRef Forsberg JA, Sjoberg D, Chen Q-R, Vickers A, Healey JH. Treating metastatic disease: Which survival model is best suited for the clinic? Clin Orthop Relat Res. 2013;471:843–850.PubMedCentralPubMedCrossRef
6.
go back to reference Garland DE. Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain injured populations. Clin Orthop Relat Res. 1988;233:86–101.PubMed Garland DE. Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain injured populations. Clin Orthop Relat Res. 1988;233:86–101.PubMed
7.
go back to reference Garland DE, Dowling V. Forearm fractures in the head-injured adult. Clin Orthop Relat Res. 1983;176:190–196.PubMed Garland DE, Dowling V. Forearm fractures in the head-injured adult. Clin Orthop Relat Res. 1983;176:190–196.PubMed
8.
go back to reference Garland DE, Rothi B, Waters RL. Femoral fractures in head-injured adults. Clin Orthop Relat Res. 1982;166:219–225.PubMed Garland DE, Rothi B, Waters RL. Femoral fractures in head-injured adults. Clin Orthop Relat Res. 1982;166:219–225.PubMed
9.
go back to reference Garland DE, Toder L. Fractures of the tibial diaphysis in adults with head injuries. Clin Orthop Relat Res. 1980;150:198–202.PubMed Garland DE, Toder L. Fractures of the tibial diaphysis in adults with head injuries. Clin Orthop Relat Res. 1980;150:198–202.PubMed
10.
go back to reference Ho TK. The random subspace method for constructing decision forests. IEEE Trans Pattern Anal Mach Intell. 1998;20:832–844.CrossRef Ho TK. The random subspace method for constructing decision forests. IEEE Trans Pattern Anal Mach Intell. 1998;20:832–844.CrossRef
11.
go back to reference Jackson WM, Aragon AB, Bulken-Hoover JD, Nesti LJ, Tuan RS. Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res. 2009;27:1645–1651.PubMedCentralPubMedCrossRef Jackson WM, Aragon AB, Bulken-Hoover JD, Nesti LJ, Tuan RS. Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res. 2009;27:1645–1651.PubMedCentralPubMedCrossRef
13.
go back to reference Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007;170:620–632.PubMedCentralPubMedCrossRef Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007;170:620–632.PubMedCentralPubMedCrossRef
15.
go back to reference Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476–486.PubMedCrossRef Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476–486.PubMedCrossRef
17.
go back to reference Steinberg GG, Hubbard C. Heterotopic ossification after femoral intramedullary rodding. J Orthop Trauma. 1993;7:536–542.PubMedCrossRef Steinberg GG, Hubbard C. Heterotopic ossification after femoral intramedullary rodding. J Orthop Trauma. 1993;7:536–542.PubMedCrossRef
Metadata
Title
Preventing Heterotopic Ossification in Combat Casualties—Which Models Are Best Suited for Clinical Use?
Authors
Keith A. Alfieri, MD
Benjamin K. Potter, MD
Thomas A. Davis, PhD
Matthew B. Wagner, PhD
Eric A. Elster, MD
Jonathan A. Forsberg, MD
Publication date
01-09-2015
Publisher
Springer US
Published in
Clinical Orthopaedics and Related Research® / Issue 9/2015
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-015-4302-1

Other articles of this Issue 9/2015

Clinical Orthopaedics and Related Research® 9/2015 Go to the issue

Symposium: Research Advances After a Decade of War

Osteoblasts Have a Neural Origin in Heterotopic Ossification